| scholarly article | Q13442814 |
| P50 | author | Kerstin Lindblad-Toh | Q6394763 |
| Hannes Lohi | Q11861362 | ||
| Claire M Wade | Q30530695 | ||
| Robert D. Schnabel | Q37369945 | ||
| Fred A. Wininger | Q45336688 | ||
| Stephanie McKay | Q55396921 | ||
| Daniel Martin Katz | Q96086009 | ||
| Eija H. Seppälä | Q114128286 | ||
| P2093 | author name string | Jeremy F Taylor | |
| Rong Zeng | |||
| Dennis P O'Brien | |||
| Gary S Johnson | |||
| Fabiana H G Farias | |||
| Douglas N Sanders | |||
| P433 | issue | 3 | |
| P921 | main subject | neuronal ceroid lipofuscinosis | Q4358039 |
| P304 | page(s) | 468-474 | |
| P577 | publication date | 2011-02-26 | |
| P1433 | published in | Neurobiology of Disease | Q15716606 |
| P1476 | title | A truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers. | |
| P478 | volume | 42 |
| Q92150444 | A major facilitator superfamily domain 8 frameshift variant in a cat with suspected neuronal ceroid lipofuscinosis |
| Q34055332 | A one base pair deletion in the canine ATP13A2 gene causes exon skipping and late-onset neuronal ceroid lipofuscinosis in the Tibetan terrier |
| Q35536486 | A rare homozygous MFSD8 single-base-pair deletion and frameshift in the whole genome sequence of a Chinese Crested dog with neuronal ceroid lipofuscinosis |
| Q28116203 | ATP13A2 and Alpha-synuclein: a Metal Taste in Autophagy |
| Q92907232 | ATP13A2 missense variant in Australian Cattle Dogs with late onset neuronal ceroid lipofuscinosis |
| Q34774337 | ATP13A2/PARK9 Deficiency Neither Cause Lysosomal Impairment Nor Alter α-Synuclein Metabolism in SH-SY5Y Cells |
| Q92586724 | Advances in the Genetics of Parkinson's Disease: A Guide for the Clinician |
| Q36748089 | Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts |
| Q36787223 | Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficits |
| Q27324195 | Audiogenic reflex seizures in cats |
| Q37375544 | Australian Cattle Dogs with Neuronal Ceroid Lipofuscinosis are Homozygous for a CLN5 Nonsense Mutation Previously Identified in Border Collies |
| Q38090658 | Canine epilepsy as a translational model? |
| Q37950831 | Canine epilepsy genetics. |
| Q47786937 | Canine neuronal ceroid lipofuscinoses: Promising models for preclinical testing of therapeutic interventions |
| Q27003886 | Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disorders |
| Q35795120 | Characterization of cellular protective effects of ATP13A2/PARK9 expression and alterations resulting from pathogenic mutants |
| Q43868552 | Characterization of neuronal ceroid-lipofuscinosis in 3 cats |
| Q33900218 | Classification of Involuntary Movements in Dogs: Myoclonus and Myotonia |
| Q92686541 | Clinical and genetic analysis of ATP13A2 in hereditary spastic paraplegia expands the phenotype |
| Q91756836 | Clinical features and genetic spectrum in Chinese patients with recessive hereditary spastic paraplegia |
| Q89976514 | Cognitive Abilities of Dogs with Mucopolysaccharidosis I: Learning and Memory |
| Q26851653 | DNA testing in neurologic diseases |
| Q48788268 | Deregulation of biometal homeostasis: the missing link for neuronal ceroid lipofuscinoses? |
| Q33642938 | Deregulation of subcellular biometal homeostasis through loss of the metal transporter, Zip7, in a childhood neurodegenerative disorder |
| Q38838536 | Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease |
| Q51030642 | Electron-dense lamellated inclusions in 2 siblings with Kufor-Rakeb syndrome. |
| Q64780601 | Emerging links between pediatric lysosomal storage diseases and adult parkinsonism |
| Q38065116 | Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA). |
| Q52345443 | Exploring the pathogenesis of canine epilepsy using a systems genetics method and implications for anti-epilepsy drug discovery. |
| Q28658209 | Genetic and phenotypic variations of inherited retinal diseases in dogs: the power of within- and across-breed studies |
| Q41836301 | Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA). |
| Q36574210 | Genomic analyses of modern dog breeds |
| Q38386636 | Golden Retriever dogs with neuronal ceroid lipofuscinosis have a two-base-pair deletion and frameshift in CLN5. |
| Q92708909 | HPO-Shuffle: an associated gene prioritization strategy and its application in drug repurposing for the treatment of canine epilepsy |
| Q42328379 | Homozygous PPT1 Splice Donor Mutation in a Cane Corso Dog With Neuronal Ceroid Lipofuscinosis |
| Q35666595 | Identification of a common risk haplotype for canine idiopathic epilepsy in the ADAM23 gene |
| Q34211933 | Identification of a novel idiopathic epilepsy locus in Belgian Shepherd dogs |
| Q34629875 | Increased zinc and manganese in parallel with neurodegeneration, synaptic protein changes and activation of Akt/GSK3 signaling in ovine CLN6 neuronal ceroid lipofuscinosis |
| Q26997333 | Large animal models for Batten disease: a review |
| Q37185266 | Lessons for livestock genomics from genome and transcriptome sequencing in cattle and other mammals |
| Q47813940 | Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78). |
| Q35799128 | Mitochondrial quality control and dynamics in Parkinson's disease |
| Q35588896 | Multifocal retinopathy in Dachshunds with CLN2 neuronal ceroid lipofuscinosis |
| Q35997567 | Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis |
| Q34100399 | Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review |
| Q47843225 | Neuronal ceroid lipofuscinosis (NCL) is caused by the entire deletion of CLN8 in the Alpenländische Dachsbracke dog. |
| Q39745482 | Neuronal ceroid lipofuscinosis associated with an MFSD8 mutation in Chihuahuas |
| Q91114347 | Neuronal ceroid lipofuscinosis in a German Shorthaired Pointer associated with a previously reported CLN8 nonsense variant |
| Q47619453 | Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature |
| Q54322271 | Novel rapid genotyping assays for neuronal ceroid lipofuscinosis in Border Collie dogs and high frequency of the mutant allele in Japan. |
| Q50418431 | Parkinson disease related ATP13A2 evolved early in animal evolution. |
| Q33582743 | Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction |
| Q99585310 | Phenotypic assays in yeast and zebrafish reveal drugs that rescue ATP13A2 deficiency |
| Q37353812 | Pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis |
| Q46879665 | Selection response to DNA testing for canine ceroid lipofuscinosis in Tibetan terriers |
| Q52144841 | The Chihuahua dog: A new animal model for neuronal ceroid lipofuscinosis CLN7 disease? |
| Q34336776 | The pallidopyramidal syndromes: nosology, aetiology and pathogenesis |
| Q38434200 | The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms |
| Q35307748 | α-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2. |
Search more.